SIR 2024
Renal and GU Interventions
Marios Platon Dimopoulos, MD,MSc
Resident
University Hospital of Patras, Greece
Disclosure information not submitted.
George Nistikoulis, MD
Resident
General University Hospital of Patras, Greece
Disclosure information not submitted.
Nikos Giannikas, MD, MS
Resident
General University Hospital of Patras, Greece
Disclosure information not submitted.
Michalis Theofanis, MD
Attending Radiologist
General University Hospital of Patras, Greece
Disclosure information not submitted.
Christos Papageorgiou, MD
Attending
General University Hospital of Patras, Greece
Disclosure information not submitted.
Vasiliki Taki, MD
Resident
General University Hospital of Patras, Greece
Disclosure information not submitted.
Evangelia Christodoulou, MD, MS
Resident
General University Hospital Of Patras, Greece
Disclosure information not submitted.
Konstantinos Katsanos, MD, PhD, MS
Ass Professor
General University Hospital of Patras, Greece
Disclosure information not submitted.
Dimitrios Karnabatidis, MD, PhD, EBIR, FCIRSE
Professor in Interventional Radiology
Interventional Radiology, Patras University Hospital, Greece
Disclosure information not submitted.
Panagiotis Kitrou, MD, PhD
Asst. Prof. in Interventional Radiology
Patras University Hospital, Greece
Disclosure information not submitted.
Procedural success was 100%. Mean follow-up was 643 ± 468 days. HPB angioplasty was performed in 50 cases (50/90, 55.5%), PCBs were used in 14 cases (14/90, 15.6%) and CS were used in 26 cases (26/90, 28.9%). TLPP at 6 months was 54% for the HPB-group, 78.57% for the PCB group and 80.77% for CS-group (p< 0.0001) and 31.9%, 64.3% and 76.9% at 12 months respectively.
Conclusion: In this retrospective analysis PCBs and CSs had similar results for the treatment of CAS and significantly better to HPB angioplasty.